Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANT-TN in Idiopathic Trigeminal Neuralgia
NCT07673549Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2027
01
Overview
Randomised trial of aciclovir and celecoxib oral solution in Idiopathic Trigeminal Neuralgia (TN) (3 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Visual Analogue Scale Pain Score at 3 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
aciclovircelecoxib oral solution
03
Conditions
Idiopathic Trigeminal Neuralgia (TN)
Beyond the preview
Go deeper on NCT07673549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07673549.